Cargando…
Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing
Background: Various three-dimensional (3D) glioblastoma cell culture models have a limited duration of viability. Our aim was to develop a long-term 3D glioblastoma model, which is necessary for reliable drug response studies. Methods: Human U87 glioblastoma cells were cultured in alginate microfibe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391761/ https://www.ncbi.nlm.nih.gov/pubmed/34439644 http://dx.doi.org/10.3390/brainsci11081025 |
_version_ | 1783743350405332992 |
---|---|
author | Dragoj, Miodrag Stojkovska, Jasmina Stanković, Tijana Dinić, Jelena Podolski-Renić, Ana Obradović, Bojana Pešić, Milica |
author_facet | Dragoj, Miodrag Stojkovska, Jasmina Stanković, Tijana Dinić, Jelena Podolski-Renić, Ana Obradović, Bojana Pešić, Milica |
author_sort | Dragoj, Miodrag |
collection | PubMed |
description | Background: Various three-dimensional (3D) glioblastoma cell culture models have a limited duration of viability. Our aim was to develop a long-term 3D glioblastoma model, which is necessary for reliable drug response studies. Methods: Human U87 glioblastoma cells were cultured in alginate microfibers for 28 days. Cell growth, viability, morphology, and aggregation in 3D culture were monitored by fluorescent and confocal microscopy upon calcein-AM/propidium iodide (CAM/PI) staining every seven days. The glioblastoma 3D model was validated using temozolomide (TMZ) treatments 3 days in a row with a recovery period. Cell viability by MTT and resistance-related gene expression (MGMT and ABCB1) by qPCR were assessed after 28 days. The same TMZ treatment schedule was applied in 2D U87 cell culture for comparison purposes. Results: Within a long-term 3D model system in alginate fibers, U87 cells remained viable for up to 28 days. On day 7, cells formed visible aggregates oriented to the microfiber periphery. TMZ treatment reduced cell growth but increased drug resistance-related gene expression. The latter effect was more pronounced in 3D compared to 2D cell culture. Conclusion: Herein, we described a long-term glioblastoma 3D model system that could be particularly helpful for drug testing and treatment optimization. |
format | Online Article Text |
id | pubmed-8391761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83917612021-08-28 Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing Dragoj, Miodrag Stojkovska, Jasmina Stanković, Tijana Dinić, Jelena Podolski-Renić, Ana Obradović, Bojana Pešić, Milica Brain Sci Article Background: Various three-dimensional (3D) glioblastoma cell culture models have a limited duration of viability. Our aim was to develop a long-term 3D glioblastoma model, which is necessary for reliable drug response studies. Methods: Human U87 glioblastoma cells were cultured in alginate microfibers for 28 days. Cell growth, viability, morphology, and aggregation in 3D culture were monitored by fluorescent and confocal microscopy upon calcein-AM/propidium iodide (CAM/PI) staining every seven days. The glioblastoma 3D model was validated using temozolomide (TMZ) treatments 3 days in a row with a recovery period. Cell viability by MTT and resistance-related gene expression (MGMT and ABCB1) by qPCR were assessed after 28 days. The same TMZ treatment schedule was applied in 2D U87 cell culture for comparison purposes. Results: Within a long-term 3D model system in alginate fibers, U87 cells remained viable for up to 28 days. On day 7, cells formed visible aggregates oriented to the microfiber periphery. TMZ treatment reduced cell growth but increased drug resistance-related gene expression. The latter effect was more pronounced in 3D compared to 2D cell culture. Conclusion: Herein, we described a long-term glioblastoma 3D model system that could be particularly helpful for drug testing and treatment optimization. MDPI 2021-07-31 /pmc/articles/PMC8391761/ /pubmed/34439644 http://dx.doi.org/10.3390/brainsci11081025 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dragoj, Miodrag Stojkovska, Jasmina Stanković, Tijana Dinić, Jelena Podolski-Renić, Ana Obradović, Bojana Pešić, Milica Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title_full | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title_fullStr | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title_full_unstemmed | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title_short | Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing |
title_sort | development and validation of a long-term 3d glioblastoma cell culture in alginate microfibers as a novel bio-mimicking model system for preclinical drug testing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391761/ https://www.ncbi.nlm.nih.gov/pubmed/34439644 http://dx.doi.org/10.3390/brainsci11081025 |
work_keys_str_mv | AT dragojmiodrag developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT stojkovskajasmina developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT stankovictijana developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT dinicjelena developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT podolskirenicana developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT obradovicbojana developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting AT pesicmilica developmentandvalidationofalongterm3dglioblastomacellcultureinalginatemicrofibersasanovelbiomimickingmodelsystemforpreclinicaldrugtesting |